Over the last 30 years, concomitant with successful transnational disease control programs
across Latin America, Chagas disease has expanded from a neglected, endemic parasitic …

Chagas disease, caused by the protozoan Trypanosoma cruzi, has a variable clinical
course, ranging from symptomless infection to severe chronic disease with cardiovascular or …

Congenital transmission of Trypanosoma cruzi may occur in some or all the gestations from
a T. cruzi-infected mother. Variable rates of congenital transmission have been reported in …

Of the currently known 140 species in the family Reduviidae, subfamily Triatominae, those
which are most important as vectors of the aetiologic agent of Chagas disease …

Chagas' disease is caused by the protozoan Trypanosoma cruzi and it has a variable
clinical outcome. The basis for this variability relies in part on the complexity of the parasite …

Morpho-biological diversity of Trypanosoma cruzi has been known since Chagas' first works
in 1909. Several further studies confirmed the morphological differences among the parasite …

Therapeutic failure of benznidazole (BZ) is widely documented in Chagas disease and has
been primarily associated with variations in the drug susceptibility of Trypanosoma cruzi …

Background Chagas disease is an emergent tropical disease in the Brazilian Amazon
Region, with an increasing number of cases in recent decades. In this region, the sylvatic …

The Leishmania donovani complex, which consists of L. donovani, L. infantum-L. chagasi,
and L. archibaldi, is responsible for visceral manifestations of leishmaniasis. Multilocus …

Background The evolutionary history and ecological associations of Trypanosoma cruzi, the
need to identify genetic markers that can distinguish parasite subpopulations, and …